Felocell CVR

Country: United Kingdom

Bahasa: Inggeris

Sumber: VMD (Veterinary Medicines Directorate)

Bahan aktif:

Feline calicivirus, Feline panleukopenia virus, Feline viral rhinotracheitis virus

Boleh didapati daripada:

Eli Lilly and Company Limited

Kod ATC:

–QI06A

INN (Nama Antarabangsa):

Feline calicivirus, Feline panleukopenia virus, Feline viral rhinotracheitis virus

Borang farmaseutikal:

Powder and solvent for solution for injection

Jenis preskripsi:

POM-V - Prescription Only Medicine – Veterinarian

Kumpulan terapeutik:

Cats

Kawasan terapeutik:

Live Viral Vaccine

Status kebenaran:

Expired

Tarikh kebenaran:

2005-10-28

Ciri produk

Revised: December 2010
AN: 01349/2010
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
FELOCELL™ CVR
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of Felocell CVR (1 ml) contains the following:
ACTIVE SUBSTANCE(S)
Live attenuated feline enteritis (panleucopaenia) virus (FPV), Snow
Leopard
strain, minimum titre: 103.0 CCID50*
Live attenuated feline rhinotracheitis virus (FVR), strain FVRm,
minimum titre:
105.0 CCID50*
Live attenuated Calicivirus (FCV), strain F9, minimum titre: 105.5
CCID50*
*Cell culture infectious dose-50
DILUENT:
Water for injection.
For full list of excipients, see Section 6.1.
3.
PHARMACEUTICAL FORM
Lyophilisate and solvent for solution for injection.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats from 9 weeks of age.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of cats to reduce mortality and clinical signs of
disease
caused by feline enteritis (panleucopaenia) virus, to reduce clinical
signs of
disease caused by feline rhinotracheitis virus and to prevent clinical
signs of
disease and reduce infection caused by feline calicivirus.
Onset of immunity occurs by approximately 3 weeks after the last dose
of the
Basic
Vaccination Scheme.
The duration of immunity is at least 12 months.
4.3
CONTRAINDICATIONS
Unhealthy animals should not be vaccinated.
Revised: December 2010
AN: 01349/2010
Page 2 of 4
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
The feline panleucopaenia virus and the feline calicivirus vaccinal
strains may
be shed from vaccinated animals for a number of days following
vaccination.
However, due to the low pathogenicity of these strains, it is not
necessary to
keep vaccinated animals separated from non-vaccinated animals.
Moderate to high levels of maternally derived antibodies (MDA) may
interfere
with the
response to vaccination.
4.5
SPECIAL PRECAUTIONS FOR USE
i. Special precautions for use in animals
None.
ii. Special precautions to be taken by the person administering the
veterinary
medicinal produ